内大麻素系统
背景(考古学)
肠-脑轴
微生物群
疾病
神经科学
痴呆
肠道菌群
认知功能衰退
生物
医学
生物信息学
免疫学
受体
病理
遗传学
古生物学
作者
Tiziana Bisogno,Anna Lauritano,Fabiana Piscitelli
出处
期刊:Life
[Multidisciplinary Digital Publishing Institute]
日期:2021-09-08
卷期号:11 (9): 934-934
被引量:16
摘要
Alzheimer's disease (AD) is a neurodegenerative disease that progresses from mild cognitive impairment to severe dementia over time. The main clinical hallmarks of the disease (e.g., beta-amyloid plaques and neurofibrillary tangles) begin during preclinical AD when cognitive deficits are not yet apparent. Hence, a more profound understanding of AD pathogenesis is needed to develop new therapeutic strategies. In this context, the endocannabinoid (eCB) system and the gut microbiome are increasingly emerging as important players in maintaining the general homeostasis and the health status of the host. However, their interaction has come to light just recently with gut microbiota regulating the eCB tone at both receptor and enzyme levels in intestinal and adipose tissues. Importantly, eCB system and gut microbiome, have been suggested to play a role in AD in both animal and human studies. Therefore, the microbiome gut-brain axis and the eCB system are potential common denominators in the AD physiopathology. Hence, the aim of this review is to provide a general overview on the role of both the eCB system and the microbiome gut-brain axis in AD and to suggest possible mechanisms that underlie the potential interplay of these two systems.
科研通智能强力驱动
Strongly Powered by AbleSci AI